Zoltán Mátrai

1.0k total citations
30 papers, 561 citations indexed

About

Zoltán Mátrai is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Zoltán Mátrai has authored 30 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 9 papers in Pathology and Forensic Medicine and 7 papers in Molecular Biology. Recurrent topics in Zoltán Mátrai's work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Zoltán Mátrai is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Zoltán Mátrai collaborates with scholars based in Hungary, United Kingdom and Poland. Zoltán Mátrai's co-authors include Ke Lin, Paul D. Sherrington, John C. Cawley, Andrew R. Pettitt, Mirko Zuzel, János Tomcsányi, Joseph R. Slupsky, David Allsup, Aura S. Kamiguti and Donát Alpár and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Zoltán Mátrai

27 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zoltán Mátrai Hungary 10 429 289 214 140 89 30 561
Jennifer Orchard United Kingdom 12 590 1.4× 435 1.5× 286 1.3× 99 0.7× 97 1.1× 16 742
Fiona Bennett United Kingdom 8 511 1.2× 391 1.4× 316 1.5× 94 0.7× 74 0.8× 12 585
Alison Morilla United Kingdom 13 653 1.5× 587 2.0× 377 1.8× 83 0.6× 173 1.9× 26 838
Anna Johnson Sweden 7 605 1.4× 554 1.9× 378 1.8× 88 0.6× 154 1.7× 10 786
Michael J. Eckart Germany 7 648 1.5× 507 1.8× 397 1.9× 195 1.4× 156 1.8× 13 928
Maurice Navarro France 6 357 0.8× 320 1.1× 187 0.9× 59 0.4× 67 0.8× 13 500
Daniel Heintel Austria 13 346 0.8× 289 1.0× 168 0.8× 442 3.2× 205 2.3× 30 846
Silvia Zibellini Italy 13 629 1.5× 459 1.6× 242 1.1× 154 1.1× 129 1.4× 29 761
Anton Parker United Kingdom 12 433 1.0× 309 1.1× 236 1.1× 281 2.0× 81 0.9× 24 673
Nicholas Tsakmaklis United States 13 698 1.6× 601 2.1× 294 1.4× 76 0.5× 96 1.1× 29 756

Countries citing papers authored by Zoltán Mátrai

Since Specialization
Citations

This map shows the geographic impact of Zoltán Mátrai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoltán Mátrai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoltán Mátrai more than expected).

Fields of papers citing papers by Zoltán Mátrai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoltán Mátrai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoltán Mátrai. The network helps show where Zoltán Mátrai may publish in the future.

Co-authorship network of co-authors of Zoltán Mátrai

This figure shows the co-authorship network connecting the top 25 collaborators of Zoltán Mátrai. A scholar is included among the top collaborators of Zoltán Mátrai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoltán Mátrai. Zoltán Mátrai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farkas, Péter, Eid Hanna, Judit Demeter, et al.. (2021). Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. Pathology. 54(1). 95–103. 5 indexed citations
2.
Rendeiro, André F., Thomas Krausgruber, Nikolaus Fortelny, et al.. (2020). Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL. Nature Communications. 11(1). 577–577. 64 indexed citations
3.
Alpár, Donát, Noémi Nagy, Ákos Nagy, et al.. (2019). Dissection of Subclonal Evolution by Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. Clinical Lymphoma Myeloma & Leukemia. 19. S279–S279. 3 indexed citations
4.
Mátrai, Zoltán, et al.. (2018). Az IGHV mutációanalízis jelentősége krónikus lymphocytás leukémiában. 51(1). 22–29.
5.
Kajtár, Béla, Judit Demeter, Miklós Egyed, et al.. (2017). A TP53-mutáció-analízis jelentősége krónikus lymphocytás leukaemiában | TP53mutation analysis in chronic lymphocytic leukaemia. 4 indexed citations
6.
Tomcsányi, János, et al.. (2016). Ibrutinib, an Approved Tyrosine Kinase Inhibitor as a Potential Cause of Recurrent Polymorphic Ventricular Tachycardia. JACC. Clinical electrophysiology. 2(7). 847–849. 28 indexed citations
7.
Mátrai, Zoltán, Hajnalka Andrikovics, Anikó Szilvási, et al.. (2016). Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia. Pathology & Oncology Research. 23(1). 165–171. 5 indexed citations
8.
Ágoston, Péter, et al.. (2014). [Role of radiotherapy in the treatment of retroperitoneal soft tissue sarcomas].. PubMed. 58(1). 77–82. 3 indexed citations
9.
Ágoston, Péter, et al.. (2014). [Radiotherapy of soft tissue sarcomas of the extremities and superficial trunk].. PubMed. 58(1). 65–76. 1 indexed citations
10.
Mátrai, Zoltán, et al.. (2012). Autologous fat transplantation in the modern reconstructive surgery of breast cancer. Orvosi Hetilap. 153(46). 1816–1831. 2 indexed citations
11.
Andrikovics, Hajnalka, Árpád Bátai, András Bors, et al.. (2011). The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia. Haematologica. 96(11). 1613–1618. 14 indexed citations
12.
Mátrai, Zoltán, et al.. (2009). Serum β2-microglobulin measured by immunonephelometry: expression patterns and reference intervals in healthy adults. Clinical Chemistry and Laboratory Medicine (CCLM). 47(5). 585–9. 15 indexed citations
13.
Mátrai, Zoltán, J. Papp, Csaba Polgár, et al.. (2009). Extraabdominalis desmoid tumorral megjelenő Gardner-syndromás beteg kezelésével szerzett hosszú távú tapasztalataink és irodalmi áttekintésr. Magyar Sebészet (Hungarian Journal of Surgery). 62(2). 75–82. 2 indexed citations
14.
Mátrai, Zoltán, et al.. (2009). Long-term experiences with multidisciplinary therapy of twenty-six patients with dermatofibrosarcoma protuberans and review of the literature. Orvosi Hetilap. 150(41). 1894–1902. 3 indexed citations
15.
Andrikovics, Hajnalka, Anikó Szilvási, Gábor Mikala, et al.. (2007). Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection. Orvosi Hetilap. 148(5). 203–210. 8 indexed citations
16.
Andrikovics, Hajnalka, et al.. (2006). Clinical Characteristics of JAK2 V617F Mutation Positive Acute Myeloid Leukemia.. Blood. 108(11). 4508–4508. 2 indexed citations
17.
Allsup, David, Aura S. Kamiguti, Ke Lin, et al.. (2005). B-Cell Receptor Translocation to Lipid Rafts and Associated Signaling Differ between Prognostically Important Subgroups of Chronic Lymphocytic Leukemia. Cancer Research. 65(16). 7328–7337. 48 indexed citations
18.
Mátrai, Zoltán, et al.. (2003). Correlation Between Cell Size and CD38 Expression in Chronic Lymphocytic Leukaemia. Leukemia & lymphoma. 44(5). 797–800. 19 indexed citations
19.
Lin, Ke, et al.. (2002). Relationship between p53 dysfunction, CD38 expression, andIgVH mutation in chronic lymphocytic leukemia. Blood. 100(4). 1404–1409. 186 indexed citations
20.
Mátrai, Zoltán, Ke Lin, Paul D. Sherrington, et al.. (2001). CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood. 97(6). 1902–1902. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Orchard Breakdown of academic impact, for papers by Fiona Bennett Breakdown of academic impact, for papers by Alison Morilla Breakdown of academic impact, for papers by Anna Johnson Breakdown of academic impact, for papers by Michael J. Eckart Breakdown of academic impact, for papers by Maurice Navarro Breakdown of academic impact, for papers by Daniel Heintel Breakdown of academic impact, for papers by Silvia Zibellini Breakdown of academic impact, for papers by Anton Parker Breakdown of academic impact, for papers by Nicholas Tsakmaklis
Rankless by CCL
2026